Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map
Engineering resilient community pharmacies for chronic care management: Protokoll zur Entwicklung einer Medication Safety Map
JMIR Research Protocols · 2025-09-11 · 14 · e69011
DOI: 10.2196/69011 ↗Auf einen Blick
Geplant ist die Entwicklung und Erprobung von MedSafeMap für sichere Medikamentenanwendung in Community-Apotheken bei komplexen chronischen Erkrankungen. Das Protokoll beschreibt ein mehrstufiges, partizipatives Vorgehen.
Fragestellung
Es soll ein CCM-System mit MedSafeMap entwickelt und evaluiert werden, das sichere Medikamentenanwendung unterstützt.
Methode
Protokoll mit partizipativem Design und Human-Factors-Methoden; 3 Aims, 6 Apothekenstandorte, Beobachtungen, Interviews, Fokusgruppen und Simulationen.
Ergebnisse
Bis August 2025 wurden 6 Apothekenstandorte rekrutiert. 3 von 4 Beobachtungsrunden, 2 Interviewrunden mit 12 Apotheker:innen und 12 Techniker:innen sowie 6 Fokusgruppen sind abgeschlossen.
Einschränkungen
Protokoll; Wirksamkeit und Auswirkungen werden erst im Pilottest untersucht.
Schlussfolgerung der Autor:innen
MedSafeMap ist ein innovativer Ansatz, der Apotheker:innen und Techniker:innen bei der sicheren Versorgung von Patient:innen mit komplexen chronischen Gesundheitsproblemen unterstützen soll.
Kernaussagen
- MedSafeMap soll sichere Medikationsprozesse in Community-Apotheken unterstützen
- 3 Aims: Anforderungen, Entwicklung und Pilottest in Apotheken
- Daten aus Beobachtungen, Interviews, Fokusgruppen und Simulationen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Studienprotokoll in JMIR Research Protocols, published online on 2025-09-11. Written by Michelle A Chui and 7 co-authors. Institution: Chui SAMS (Systems Approach to Medication Safety) Lab, School of Nursing, University of Wisconsin-Madison, Madison, WI, United States. Major MEDLINE topics: Community Pharmacy Services, Pharmacies, Patient Safety. Cited 2 times so far (Crossref); 80 references. The full text is freely available in PubMed Central. Funded by: AHRQ HHS.
Topics: Medikationssicherheit
Abstract (original language)
Background
The increase in people with complex chronic health conditions is stressing the US health care delivery system. Community pharmacies play a role in ensuring patients’ safe medication use for chronic care management (CCM), but their efforts are undermined by volatile work demands and other system barriers. Medication safety in community pharmacies is a multidimensional issue shaped by the work system and interactions among pharmacists, primary care providers, and patients.
Objective
The objective is to create and evaluate a system of CCM that supports safe medication use. The CCM system design will focus on creating and evaluating a Medication Safety Map (MedSafeMap) for patients with complex chronic health conditions. This study has three aims: (1) identify and define community pharmacy work system design requirements for safe medication practices, enabling resilient performance; (2) design and develop MedSafeMap, a feasible and sustainable solution, to facilitate safe medication practices through resilient performance; and (3) implement MedSafeMap in community pharmacies and pilot-test its impact on pharmacy staff attitudes, behaviors, and performance.
Methods
This study will leverage participatory design and human factors engineering methods throughout the 3 aims. For aim 1, four rounds of qualitative observations within 6 pharmacy sites will be conducted to parse areas MedSafeMap could address. Two rounds of interviews with pharmacists and technicians from each of the sites will be used to expand upon areas of interest identified during the observations. Observational and interview data will be used to construct functional resonance analysis method models and resilience narratives to map both risks and best practices within the system based on daily workplace factors. For aim 2, focus groups with pharmacist and technician stakeholders will be guided by participatory stakeholder engagement to inform prototyping for MedSafeMap. Simulation-based research involving standardized patients in CCM scenarios will be used to test and refine MedSafeMap components. Finally, for aim 3, MedSafeMap will be implemented in pharmacies. Observations using the work observation method by activity timing (WOMBAT) for the time and motion study will aid in understanding how MedSafeMap impacts pharmacy staff workflow. We will assess adoption challenges and resilience-focused attitudes, behaviors, and performance to support CCM.
Results
As of August 2025, all 6 pharmacy sites have been recruited. Three of the 4 rounds of observations, 2 rounds of interviews with 12 pharmacists and 12 technicians from the study sites, and the 6 focus groups have been conducted. Preparations for the simulations are ongoing.
Conclusions
MedSafeMap is an innovative approach that will guide pharmacists and technicians in safely providing care to patients with complex chronic health conditions. It will help them navigate the complex tasks and communications between the pharmacy, patient, and primary care provider arising with this type of complex care. International Registered Report Identifier (IRRID) DERR1-10.2196/69011
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Chui SAMS (Systems Approach to Medication Safety) Lab, School of Nursing, University of Wisconsin-Madison, Madison, WI, United States.
- Sonderegger Research Center, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, United States.
- Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, United States.
- Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
- Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
ORCID profiles: Michelle A Chui, Maria E Berbakov, Aaron M Gilson, Jamie A Stone, Elin C Lehnbom, Emily L Hoffins, Katherine G Moore, James H Ford Ii
Funding
- AHRQ HHS
Cite
APA
Chui, M. A., Berbakov, M. E., Gilson, A. M., Stone, J. A., Lehnbom, E. C., Hoffins, E. L., Moore, K. G., & Ford Ii, J. H. (2025). Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map. JMIR Research Protocols, 14, e69011. https://doi.org/10.2196/69011
Vancouver
Chui MA, Berbakov ME, Gilson AM, Stone JA, Lehnbom EC, Hoffins EL, et al. Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map. JMIR Research Protocols. 2025;14:e69011. doi:10.2196/69011
BibTeX
@article{Chui2025,
author = {Chui, Michelle A and Berbakov, Maria E and Gilson, Aaron M and Stone, Jamie A and Lehnbom, Elin C and Hoffins, Emily L and Moore, Katherine G and Ford Ii, James H},
title = {Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map},
journal = {JMIR Research Protocols},
year = {2025},
volume = {14},
pages = {e69011},
doi = {10.2196/69011}
}
EUVIMED